系统的挖掘和量化揭示了非HLA变异对急性移植对宿主疾病的主要贡献

Shuang Liang1,2, Yu-Jian Kang3,4, Mingrui Huo1

  • 1Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China.

概括

非人类白细胞抗原 (HLA) 遗传变异显著影响移植后急性移植与宿主疾病 (aGVHD) 风险,独立于HLA匹配. 这一发现为供体选择和理解移植免疫学提供了新的策略.